JYNT Stock Analysis: Buy, Sell, or Hold?

JYNT - The Joint Corp.

PATENT OWNERS & LESSORS
$8.57
0.22 (2.63%) ▲
5d: +0.94%
30d: -2.61%
90d: -2.17%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 14, 2026
Smart Money Accumulation

JYNT is down 10.7% this week, but smart money is accumulating calls. Top strike: $7.5 2026-03-20 with 1 OI. Call ratio: 100% View Scanner →

Strength: 10.0/10

Get Alerted When JYNT Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
✅ BUY SIGNAL: JYNT shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$4.80
Based on -3.0% avg growth
INTRINSIC VALUE TODAY
$2.98
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: JYNT is currently trading at $8.57, which is considered fair relative to its 30-day fair value range of $8.31 to $8.99. From a valuation perspective, the stock is trading at a premium (Forward PE: 37.1) compared to its historical average (32.0). At these levels, the market is pricing in 5.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, JYNT is showing sideways momentum. Immediate support is located at $7.83, while resistance sits at $8.89.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $10.00 (+19.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $8.31 - $8.99
Company Quality Score 56/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 75.8%

All Signals

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 0th percentile)
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading below Wall St target ($10.00)
  • NEUTRAL: PE elevated vs history but 5.1% growth expectation is conservative given 6277% recent growth

Fair Price Analysis

30-Day Fair Range $8.31 - $8.99
Current vs Fair Value FAIR
Expected Move (7 Days) ±$0.84 (9.8%)

Support & Resistance Levels

Support Level $7.84
Resistance Level $8.89
Current Trend Sideways
Technical data as of Mar 30, 2026

Fundamental Context

Forward P/E (Next Year Est.) 37.11
Wall Street Target $10.00 (+19.8%)
Revenue Growth (YoY) 3.1%
Earnings Growth (YoY) 6276.7%
Profit Margin 5.3%
Valuation Premium vs History +5.1% premium
PE vs Historical 37.1 vs 32.0 STRETCHED
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): +5.1% (market-implied from PE analysis)
1-Year Target $8.78 (+5%)
2-Year Target $9.22 (+11%)
3-Year Target $9.69 (+16%)
3-Yr Target (if PE normalizes) (PE: 37→32) PE COMPRESSION $8.36 (+0%)
Earnings growth offset by PE compression
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 37.1, Growth: -10.0%) $6.09 (+-27%)
Base: (SPY PE: 22.4, Growth: -10.0%) $3.67 (-56%)
Bear: (PE: 19.0, Growth: -10.0%) $3.12 (-63%)
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: March 30, 2026 2:45 PM ET
Data refreshes hourly during market hours. Next update: 3:45 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
8
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Charles E Jobson BUY 15397 shares 2026-02-12
Charles E Jobson BUY 448 shares 2026-02-11
Charles E Jobson BUY 16753 shares 2026-01-23

Unlock Insider Activity

See real-time buying/selling by company executives for JYNT.

Create Free Account

Already have an account? Log In

Top Rated Medical Care Facilities Stocks

Top-rated stocks in Medical Care Facilities by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
THC
Tenet Healthcare Corpora…
STRONG BUY
22 analysts
$261 62 BUY
HCA
HCA Holdings Inc
BUY
25 analysts
$543 64 BUY
EHC
Encompass Health Corp
STRONG BUY
12 analysts
$143 56 HOLD
CMPS
Compass Pathways Plc
STRONG BUY
11 analysts
$22 48 HOLD
ADUS
Addus HomeCare Corporati…
STRONG BUY
11 analysts
$140 54 HOLD

Advanced JYNT Option Strategies

Professional options setups generated by AI based on today's JYNT price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for JYNT

JYNT Technical Chart JYNT Price Prediction JYNT Earnings Date JYNT Investment Advisor JYNT Fair Price Analyzer JYNT Options Advisor JYNT Options Chain JYNT Options Analysis JYNT Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals